Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis GlobeNewswire - Tue May 26, 7:02AM CDT

Enrollment is tracking ahead of schedule, allowing potential acceleration of key trial milestones Minimum enrollment to support interim analysis expected as soon as early July 2026 Randomized, double-blind,...

SXTP : 1.4900 (unch)
SXTPW : 0.0393 (-0.51%)
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results GlobeNewswire - Fri May 15, 7:42AM CDT

WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc.  (NASDAQ:  SXTP ; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious...

SXTP : 1.4900 (unch)
SXTPW : 0.0393 (-0.51%)
RedChip's Biotech Investor Conference Replays Now Available ACCESS Newswire - Mon Apr 20, 3:00AM CDT

ORLANDO, FL / ACCESS Newswire / April 20, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand replays...

NXL : 0.6100 (+4.45%)
BIVI : 1.4200 (-1.39%)
SXTP : 1.4900 (unch)
BFRG : 0.7576 (+5.22%)
LTRN : 3.59 (+2.57%)
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website GlobeNewswire - Wed Apr 15, 7:02AM CDT

Travelers can now purchase the only once-weekly, broad-spectrum malaria preventive online, through the Runway Health telehealth platform WASHINGTON, April 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees...

SXTP : 1.4900 (unch)
SXTPW : 0.0393 (-0.51%)
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ACCESS Newswire - Thu Apr 2, 4:00AM CDT

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies will air interviews with Infrastructure Capital Advisors, LLC (NYSE:SCAP)(NYSE:PFFA)(NYSE:BNDS) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP)...

BNDS : 50.88 (+0.03%)
PFFA : 21.36 (-0.09%)
SXTP : 1.4900 (unch)
SCAP : 38.47 (-0.24%)
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference ACCESS Newswire - Thu Apr 2, 3:45AM CDT

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming virtual...

NXL : 0.6100 (+4.45%)
BIVI : 1.4200 (-1.39%)
SXTP : 1.4900 (unch)
BFRG : 0.7576 (+5.22%)
LTRN : 3.59 (+2.57%)
60 Degrees Pharmaceuticals Announces 2025 Annual Results GlobeNewswire - Tue Mar 31, 6:01AM CDT

FY 2025 net product revenues increased 65% to $1,005,000 Current shelf capacity exhausted after raise of $4 million through an ATM facility WASHINGTON, March 31, 2026 (GLOBE NEWSWIRE) -- 60 Degrees...

SXTP : 1.4900 (unch)
SXTPW : 0.0393 (-0.51%)
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract GlobeNewswire - Wed Mar 18, 7:01AM CDT

FDA has until May 25, 2026 to object to the notification, after which the Company will be free to market its proposed dietary supplement containing Australian Chestnut Extract Company has signed an option...

SXTP : 1.4900 (unch)
SXTPW : 0.0393 (-0.51%)
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial GlobeNewswire - Wed Mar 11, 6:24AM CDT

All three patients enrolled in study have been cured, confirming high cure rate of  tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publication Company calls for existing babesiosis...

SXTP : 1.4900 (unch)
SXTPW : 0.0393 (-0.51%)
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ACCESS Newswire - Fri Feb 27, 3:00AM CST

ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks,...

BIVI : 1.4200 (-1.39%)
SXTP : 1.4900 (unch)

Barchart Exclusives

Why Cathie Wood Is Pounding the Table for $750,000 Bitcoin: A New Generation Loves Crypto to Hedge Against Inflation Barchart - Sat May 30, 2:00PM CDT
The star fund manager believes that the crypto's price can reach $1.25 million per coin. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.